Log in

NYSE:CLSCelestica Stock Price, Forecast & News

$6.79
+0.13 (+1.95 %)
(As of 07/10/2020 04:00 PM ET)
Add
Compare
Today's Range
$6.61
Now: $6.79
$6.84
50-Day Range
$6.09
MA: $6.71
$7.69
52-Week Range
$2.63
Now: $6.79
$9.29
Volume180,300 shs
Average Volume308,903 shs
Market Capitalization$876.25 million
P/E RatioN/A
Dividend YieldN/A
Beta2.17
Celestica Inc. provides design, manufacturing, hardware platform, and supply chain solutions in Canada and internationally. It operates through two segments, Advanced Technology Solutions, and Connectivity & Cloud Solutions. The company offers a range of services, including design and development, engineering, supply chain management, new product introduction, component sourcing, electronics manufacturing, assembly and test, complex mechanical assembly, systems integration, precision machining, order fulfillment, logistics, asset management, product licensing, and after-market repair and return services. It serves the aerospace and defense, industrial, smart energy, healthtech, capital equipment, enterprise communications, telecommunications, servers, and storage businesses. The company was incorporated in 1996 and is headquartered in Toronto, Canada.
Read More
Celestica logo

Beat the Market (BTM) Rank

Analyst Opinion: 1.9Community Rank: 1.9Dividend Strength: 0.0Insider Behavior: 1.0Valuation: 3.1 5 -4 -3 -2 -1 -

Overall Beat the Market Rank

1.59 out of 5 stars


Industry, Sector and Symbol

Industry Printed circuit boards
Sub-IndustryN/A
CUSIPN/A
Phone416-448-2211

Debt

Price-To-Earnings

Sales & Book Value

Annual Sales$5.89 billion
Cash Flow$1.64 per share
Book Value$10.53 per share

Profitability

Net Income$70.30 million

Miscellaneous

Employees24,600
Market Cap$876.25 million
Next Earnings Date7/29/2020 (Confirmed)
OptionableOptionable

Receive CLS News and Ratings via Email

Sign-up to receive the latest news and ratings for CLS and its competitors with MarketBeat's FREE daily newsletter.

Celestica (NYSE:CLS) Frequently Asked Questions

How has Celestica's stock been impacted by COVID-19 (Coronavirus)?

Celestica's stock was trading at $5.07 on March 11th, 2020 when COVID-19 reached pandemic status according to the World Health Organization. Since then, CLS shares have increased by 33.9% and is now trading at $6.79. View which stocks have been most impacted by Coronavirus.

Do Wall Street analysts recommend investors buy shares of Celestica?

7 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Celestica in the last year. There are currently 1 sell rating and 6 hold ratings for the stock, resulting in a consensus recommendation of "Hold." View analyst ratings for Celestica.

When is Celestica's next earnings date?

Celestica is scheduled to release its next quarterly earnings announcement on Wednesday, July 29th 2020. View our earnings forecast for Celestica.

How can I listen to Celestica's earnings call?

Celestica will be holding an earnings conference call on Wednesday, July 29th at 12:00 AM Eastern. Interested parties can register for or listen to the call using this link or dial in at Not Available.

How were Celestica's earnings last quarter?

Celestica Inc (NYSE:CLS) posted its earnings results on Wednesday, April, 29th. The technology company reported $0.16 earnings per share for the quarter, beating the consensus estimate of $0.11 by $0.05. The technology company had revenue of $1.32 billion for the quarter, compared to analysts' expectations of $1.25 billion. Celestica had a negative net margin of 0.40% and a positive return on equity of 2.31%. Celestica's quarterly revenue was down 8.0% on a year-over-year basis. During the same quarter last year, the company posted $0.12 EPS. View Celestica's earnings history.

What price target have analysts set for CLS?

7 brokers have issued 1 year price targets for Celestica's stock. Their forecasts range from $5.00 to $8.00. On average, they expect Celestica's stock price to reach $6.61 in the next twelve months. This suggests that the stock has a possible downside of 2.7%. View analysts' price targets for Celestica.

Has Celestica been receiving favorable news coverage?

Press coverage about CLS stock has trended somewhat negative recently, InfoTrie Sentiment reports. The research group identifies negative and positive media coverage by monitoring more than six thousand blog and news sources in real time. The firm ranks coverage of publicly-traded companies on a scale of negative five to positive five, with scores closest to five being the most favorable. Celestica earned a media sentiment score of -1.8 on InfoTrie's scale. They also assigned news articles about the technology company a news buzz of 0.0 out of 10, indicating that recent media coverage is extremely unlikely to have an effect on the company's share price in the near term. View the latest news about Celestica.

Are investors shorting Celestica?

Celestica saw a drop in short interest in the month of June. As of June 15th, there was short interest totaling 475,400 shares, a drop of 18.4% from the May 31st total of 582,700 shares. Based on an average daily volume of 681,200 shares, the short-interest ratio is currently 0.7 days. Currently, 0.4% of the company's stock are sold short. View Celestica's Current Options Chain.

Who are some of Celestica's key competitors?

What other stocks do shareholders of Celestica own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Celestica investors own include Aurora Cannabis (ACB), Quantum (QTM), Ballard Power Systems (BLDP), Portland General Electric (POR), NVIDIA (NVDA), AT&T (T), Netflix (NFLX), Shopify (SHOP), Walt Disney (DIS) and Freeport-McMoRan (FCX).

Who are Celestica's key executives?

Celestica's management team includes the following people:
  • Mr. Robert Andrew Mionis, Pres, CEO & Director (Age 56)
  • Mr. Mandeep Chawla, Chief Financial Officer (Age 42)
  • Mr. Todd Cooper, Chief Operations Officer (Age 49)
  • Mr. Michael P. McCaughey, Advisor (Age 57)
  • Mr. John Joseph Lawless, Pres of Advanced Technology Solutions (Age 58)

What is Celestica's stock symbol?

Celestica trades on the New York Stock Exchange (NYSE) under the ticker symbol "CLS."

How do I buy shares of Celestica?

Shares of CLS can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

What is Celestica's stock price today?

One share of CLS stock can currently be purchased for approximately $6.79.

How big of a company is Celestica?

Celestica has a market capitalization of $876.25 million and generates $5.89 billion in revenue each year. The technology company earns $70.30 million in net income (profit) each year or $0.54 on an earnings per share basis. Celestica employs 24,600 workers across the globe.

What is Celestica's official website?

The official website for Celestica is www.celestica.com.

How can I contact Celestica?

Celestica's mailing address is 5140 YONGE STREET SUITE 1900, TORONTO A6, M2N 6L7. The technology company can be reached via phone at 416-448-2211 or via email at [email protected]

This page was last updated on 7/11/2020 by MarketBeat.com Staff

30 Days of MarketBeat All Access for $1.00

Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools:

  • Best-in-Class Portfolio Monitoring

    View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.

  • Stock Ideas and Recommendations

    Get daily stock ideas top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.

  • Advanced Stock Screeners and Research Tools

    Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your Risk-Free Trial Subscription Here

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.